0001209191-22-037429.txt : 20220616 0001209191-22-037429.hdr.sgml : 20220616 20220616163130 ACCESSION NUMBER: 0001209191-22-037429 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220616 DATE AS OF CHANGE: 20220616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHIFF ANDREW N CENTRAL INDEX KEY: 0001172252 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40522 FILM NUMBER: 221021010 MAIL ADDRESS: STREET 1: PLANET ZANETT INC STREET 2: 135 E 57TH ST CITY: NEW YORK STATE: NY ZIP: 10022 FORMER NAME: FORMER CONFORMED NAME: SCHIFF DR DREW DATE OF NAME CHANGE: 20020426 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monte Rosa Therapeutics, Inc. CENTRAL INDEX KEY: 0001826457 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 645 SUMMER STREET STREET 2: SUITE 102 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-949-2643 MAIL ADDRESS: STREET 1: 645 SUMMER STREET STREET 2: SUITE 102 CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-15 0 0001826457 Monte Rosa Therapeutics, Inc. GLUE 0001172252 SCHIFF ANDREW N MONTE ROSA THERAPEUTICS, INC. 645 SUMMER STREET, SUITE 102 BOSTON MA 02210 1 0 0 0 Stock Option (Right to Buy) 7.66 2022-06-15 4 A 0 15000 0.00 A 2032-06-14 Common Stock 15000 15000 D The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2023 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. /s/ Ajim Tamboli, Attorney-in-Fact 2022-06-16